Send to a Friend Share

Duncan-Williams Downgrades eResearchTechnology (ERES) to Hold; Valuation Call

November 6, 2009 7:09 AM EST
ERES Hot Sheet
Rating Summary:
    2 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 1
Duncan-Williams downgrades eResearchTechnology (Nasdaq: ERES) to Hold.

Duncan analyst says, "We are downgrading ERES to a HOLD based on valuation. In our opinion, ERES has weathered the downturn in R&D spending, and the current stock price represents a fair valuation based on our revised revenue and EPS estimates. We look for improved business fundamentals and improved visibility in 2010. We believe ERES is a core holding in the Clinical Research Organization (CRO) sector...We are reducing our 2010 Service Revenue estimate to $73.8 million. Our 2010 Service Revenue estimate represents 15% growth compared to our 2009 estimate. We are reducing our 2010 Site Support Revenue estimate to $31.3 million. Our 2010 Site Support Revenue estimate represents 20% growth compared to our 2009 estimate."

To see more analyst ratings on ERES Click Here.


You May Also Be Interested In


Related Categories

Downgrades

Add Your Comment





Follow StreetInsider.com On Twitter